Drug Information

Drug General Information
Drug ID
D0H2AM
Former ID
DIB011094
Drug Name
XR-3054
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Terminated [525621]
Company
Xenova Group plc
Canonical SMILES
C1(O[C@@]2(CO1)CC[C@@H](C(=C)C)CC2)(C)C
CAS Number
CAS 247090-97-7
Target and Pathway
Target(s) Protein farnesyltransferase beta subunit Target Info Inhibitor [525621]
KEGG Pathway Terpenoid backbone biosynthesis
Biosynthesis of antibiotics
NetPath Pathway TSH Signaling Pathway
Reactome Inactivation, recovery and regulation of the phototransduction cascade
WikiPathways Visual phototransduction
References
Ref 525621XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase. Eur J Cancer. 1999 Jun;35(6):1014-9.
Ref 525621XR3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase. Eur J Cancer. 1999 Jun;35(6):1014-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.